BioSig Technologies, Inc. / Fundamentals
Income statement
- Net revenue
€11.15K - Cost of goods sold
€143.29K - Gross profit
-€132.13K - SG&A expenses
€22.81M - R&D expenses
€237.67K - EBITDA
-€22.93M - D&A
€545.69K - EBIT
-€23.58M - Interest expenses
€0.00 - EBT
-€22.46M - Tax expenses
€0.00 - Net income
-€22.48M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€8.07M - Changes in working capital
€2.48M - Operating cash flow
-€3.74M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€314.03K - Total cash dividends paid
-€10.30K - Issuance of common stock
€6.22M - Debt repayment
-€429.00K - Other financing cash flow
€437.58K - Net financing cash flow
€4.03M - Foreign exchange effects
€4.29K - Net change in cash
€614.33K - Cash at end of period
€2.42M - Free cash flow
-€3.74M
Balance sheet
- Cash and cash equivalents
€2.42M - Cash and short-term investments
€2.42M - Total receivables
€24.88K - Inventory
€0.00 - Other current assets
€130.42K - Total current assets
€2.57M - Property, plant & equipment
€57.49K - Goodwill
€50.36M - Intangible assets
€41.11M - Long-term investments
€0.00 - Other non-current assets
€37.75K - Total non-current assets
€91.57M - Total assets
€94.14M - Accounts payable
€0.00 - Short-term debt
€12.87K - Other current liabilities
€97.11M - Total current liabilities
€97.13M - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€0.00 - Total liabilities
€97.13M - Common stock
€26.60K - Retained earnings
-€238.98M - Other equity
€1.32M - Total equity
-€2.98M - Total liabilities and shareholders' equity
€94.14M
Company information
- Market capitalization
€178.33M - Employees
5 - Enterprise Value
€182.83M
Company ratios
- Gross margin
-
-1,184.6% Much worse than peer group: 29.1% - EBITDA margin
-
-205,561.5% Much worse than peer group: -5,324.8% - EBIT margin
-
-211,400.0% Much worse than peer group: -5,274.3% - EBT margin
-
-201,392.3% Much worse than peer group: -5,300.8% - Net margin
-
-201,515.4% Much worse than peer group: -5,464.5% - ROE
-
753.0% Much better than peer group: 7.5% - ROA
-
-23.9% Much better than peer group: -3,071.6% - Asset turnover
-
0.0% Much worse than peer group: 59.3% - FCF margin
-
-33,507.7% Much worse than peer group: -3,977.0% - FCF yield
-2.1% - Efficiency ratio
205,661.5% - Net sales per employee
-
€2.23K - Net income per employee
-
-€4.50M